PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PJP vs. USA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between PJP and USA is 0.57, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.6

Performance

PJP vs. USA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Pharmaceuticals ETF (PJP) and Liberty All-Star Equity Fund (USA). The values are adjusted to include any dividend payments, if applicable.

400.00%450.00%500.00%550.00%600.00%650.00%OctoberNovemberDecember2025FebruaryMarch
627.29%
388.49%
PJP
USA

Key characteristics

Sharpe Ratio

PJP:

0.81

USA:

0.89

Sortino Ratio

PJP:

1.18

USA:

1.31

Omega Ratio

PJP:

1.14

USA:

1.16

Calmar Ratio

PJP:

1.22

USA:

1.74

Martin Ratio

PJP:

3.15

USA:

4.87

Ulcer Index

PJP:

3.43%

USA:

2.56%

Daily Std Dev

PJP:

13.17%

USA:

14.08%

Max Drawdown

PJP:

-37.06%

USA:

-69.06%

Current Drawdown

PJP:

-4.20%

USA:

-4.87%

Returns By Period

In the year-to-date period, PJP achieves a 3.63% return, which is significantly higher than USA's 0.62% return. Over the past 10 years, PJP has underperformed USA with an annualized return of 2.60%, while USA has yielded a comparatively higher 12.42% annualized return.


PJP

YTD

3.63%

1M

-0.47%

6M

-3.68%

1Y

10.98%

5Y*

7.85%

10Y*

2.60%

USA

YTD

0.62%

1M

-4.07%

6M

2.69%

1Y

10.82%

5Y*

12.42%

10Y*

12.42%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PJP vs. USA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PJP
The Risk-Adjusted Performance Rank of PJP is 4242
Overall Rank
The Sharpe Ratio Rank of PJP is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of PJP is 3838
Sortino Ratio Rank
The Omega Ratio Rank of PJP is 3636
Omega Ratio Rank
The Calmar Ratio Rank of PJP is 5454
Calmar Ratio Rank
The Martin Ratio Rank of PJP is 4141
Martin Ratio Rank

USA
The Risk-Adjusted Performance Rank of USA is 7676
Overall Rank
The Sharpe Ratio Rank of USA is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of USA is 6868
Sortino Ratio Rank
The Omega Ratio Rank of USA is 6565
Omega Ratio Rank
The Calmar Ratio Rank of USA is 8989
Calmar Ratio Rank
The Martin Ratio Rank of USA is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PJP vs. USA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Liberty All-Star Equity Fund (USA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PJP, currently valued at 0.81, compared to the broader market-1.000.001.002.003.004.005.000.810.89
The chart of Sortino ratio for PJP, currently valued at 1.18, compared to the broader market-2.000.002.004.006.008.0010.001.181.31
The chart of Omega ratio for PJP, currently valued at 1.14, compared to the broader market0.501.001.502.002.503.001.141.16
The chart of Calmar ratio for PJP, currently valued at 1.22, compared to the broader market0.005.0010.0015.001.221.74
The chart of Martin ratio for PJP, currently valued at 3.15, compared to the broader market0.0020.0040.0060.0080.00100.003.154.87
PJP
USA

The current PJP Sharpe Ratio is 0.81, which is comparable to the USA Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of PJP and USA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00OctoberNovemberDecember2025FebruaryMarch
0.81
0.89
PJP
USA

Dividends

PJP vs. USA - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 0.94%, less than USA's 10.40% yield.


TTM20242023202220212020201920182017201620152014
PJP
Invesco Dynamic Pharmaceuticals ETF
0.94%0.97%1.01%0.95%0.81%0.76%0.77%1.11%0.65%0.91%5.49%2.96%
USA
Liberty All-Star Equity Fund
10.40%10.22%9.56%12.11%9.67%9.26%9.88%12.81%9.01%9.43%9.66%6.61%

Drawdowns

PJP vs. USA - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum USA drawdown of -69.06%. Use the drawdown chart below to compare losses from any high point for PJP and USA. For additional features, visit the drawdowns tool.


-8.00%-6.00%-4.00%-2.00%0.00%OctoberNovemberDecember2025FebruaryMarch
-4.20%
-4.87%
PJP
USA

Volatility

PJP vs. USA - Volatility Comparison

Invesco Dynamic Pharmaceuticals ETF (PJP) has a higher volatility of 4.16% compared to Liberty All-Star Equity Fund (USA) at 3.31%. This indicates that PJP's price experiences larger fluctuations and is considered to be riskier than USA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%OctoberNovemberDecember2025FebruaryMarch
4.16%
3.31%
PJP
USA
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab